NYSE Euronext Welcomes AbbVie to Its European and U.S. Markets

Back

 

New York, Paris, January 2, 2013 – Today,AbbVie (ticker symbol: ABBV), a global research-based biopharmaceutical company formed in 2013 following separation from Abbott (ticker symbol: ABT), marked its cross-listing on NYSE Euronext (NYX) markets in Europe and the United States by ringing the Opening Bell in New York. AbbVie used the streamlined, cost-effective Fast Path process to cross-list in Europe, making it the fifteenth company to take advantage of this procedure since it was made available by NYSE Euronext in 2008.

AbbVie’s Common Stock was admitted to listing and trading on the NYSE Euronext markets by direct listing of its approximately 1.58 billion existing shares making up its capital and representing a market capitalization of €40 billion/ $54 billion.

Richard Gonzalez, CEO of AbbVie, said: “Today AbbVie launches with an outstanding portfolio, a solid pipeline and enthusiastic people who will serve patients and deliver growth. With those assets and a relentless focus on innovation we intend to create significant value for our shareholders.”

“We welcome AbbVie to the community of NYSE Euronext listed companies and applaud its decision to cross-list on our European and U.S. markets which will reinforce its global identity”, added Scott Cutler, EVP, Head of Global Listings at NYSE Euronext. “This is the beginning of a lasting relationship that will give AbbVie the benefits of the highest levels of service, liquidity and transparency available through NYSE Euronext.”

Press Release Footer

About Euronext 
Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway and Portugal.
As of September 2025, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal host over 1,700 listed issuers with €6.5 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 25% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices.
In November 2025, Euronext successfully acquired a majority stake in the Athens Stock Exchange (ATHEX), further expanding its footprint and strengthening its pan-European market infrastructure.

For the latest news and resources, please visit the Media Centre. 
Follow us on X (x.com/euronext) and LinkedIn (linkedin.com/company/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2025, Euronext N.V. - All rights reserved.